Anthony Doyle

Anthony Doyle is a seasoned financial executive with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Chief Financial Officer at Flourish Research since April 2025, Anthony leads efforts in conducting comprehensive research studies while ensuring effective patient recruitment and retention. Prior to this role, Anthony held the CFO position at BioCryst Pharmaceuticals, overseeing the development of innovative therapeutics and contributing to the commercialization of ORLADEYO®. Anthony also served as CFO at Worldwide Clinical Trials, focusing on facilitating the development of life-changing medicines, and held the CFO title at World Book, part of Berkshire Hathaway, specializing in educational resources. Earlier experience includes key finance roles at GE Healthcare, where responsibilities encompassed managing global finance for performance solutions and leading risk and pricing strategies for diagnostic imaging products. Anthony holds a Graduate Certificate in Corporate Treasury and a BA in European Business & French from Dublin City University.